{
    "SPADE_N_15331": {
        "Sequence Information": {
            "Peptide Name": "Mauriporin / NDBP-2.8",
            "Sequence": "FKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAE",
            "Sequence Length": 48,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell",
                "Antibiofilm"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Androctonus mauritanicus",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "N0EAL3",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/N0EAL3",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Mauriporin, a Novel Cationic a-Helical Peptide with Selective Cytotoxic Activity Against Prostate Cancer Cell Lines from the Venom of the Scorpion Androctonus mauritanicus",
                    "Pubmed ID": "",
                    "Reference": "Int J Pept Res Ther. 2013;19:281-293",
                    "Author": "Almaaytah A, Tarazi S, Mhaidat N, Al-Balas Q, Mukattash TL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                },
                {
                    "Title": "Antimicrobial and Antibioﬁlm Activity of Mauriporin, a Multifunctional Scorpion Venom Peptide",
                    "Pubmed ID": "",
                    "Reference": "Int J Pept Res Ther. 2014;20:397-408",
                    "Author": "Almaaytah A, Tarazi S, Alsheyab F, Al-Balas Q, Mukattash TL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 5397.28,
            "PI": 10.09,
            "Net Charge": 6,
            "Hydrophobicity": -0.59,
            "Frequent Amino Acids": "KAE",
            "Absent Amino Acids": "CHMOQTU",
            "Basic Residues": 12,
            "Acidic Residues": 6,
            "Hydrophobic Residues": 18,
            "Polar Residues": 30,
            "Positive Residues": 12,
            "Negative Residues": 6,
            "SPADE ID": "SPADE_N_15331",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_15441",
                    "Similarity": 1.0,
                    "Sequence": "FKIGGFIKKLWRSKLA"
                },
                {
                    "SPADE_ID": "SPADE_UN_15442",
                    "Similarity": 0.9375,
                    "Sequence": "FKIGGFIKKLWRSLLA"
                },
                {
                    "SPADE_ID": "SPADE_UN_15478",
                    "Similarity": 0.9375,
                    "Sequence": "FKIGGFIKKLWRSALA"
                }
            ],
            "Hemolytic Activity": "Vero cells:IC50=59.7±0.13 µM,Human umbilical vein endothelial cells HUVEC:IC50=62.5±0.19 µM,Sheep erythrocytes:5.2% Hemolysis=100 µM,Human erythrocytes:15.4% Hemolysis=100 µM",
            "Target Organism": "Human prostate adenocarcinoma PC-3(IC50=7.7±0.24µM),Human prostate cancer DU145(IC50=4.4±0.45µM),Human prostate adenocarcinoma LNCaP(IC50=7.8±0.27µM),Listeria ivanovii ATCC 19119(MIC=5µM),Staphylococcus epidermidis ATCC 12228(MIC=10µM),Salmonella enterica subsp. enterica serovar Choleraesuis ATCC 10708(MIC=5µM),Pseudomonas aeruginosa ATCC 27853(MIC=5µM),Acinetobacter baumannii ATCC 19606(MIC=5µM),Klebsiella pneumoniae ATCC 700603(MIC=5µM),Escherichia coli ATCC 25922(IC50=7.5µM),Salmonella enterica subsp. enterica ATCC 29629(MIC=7.5µM),Pseudomonas aeruginosa ATCC 9027(MIC=10µM)"
        }
    }
}